Target
Isoform Bcl-X(L) of Bcl-2-like protein 1 (Bcl-xL)
Ligand
BDBM109235
Substrate
n/a
Meas. Tech.
AlphaScreen Assay (AS)
pH
7.4±n/a
Temperature
298.15±n/a K
IC50
1.5±0.4 nM
Comments
extracted
Citation
 Lessene, GCzabotar, PESleebs, BEZobel, KLowes, KNAdams, JMBaell, JBColman, PMDeshayes, KFairbrother, WJFlygare, JAGibbons, PKersten, WJKulasegaram, SMoss, RMParisot, JPSmith, BJStreet, IPYang, HHuang, DCWatson, KG Structure-guided design of a selective BCL-X(L) inhibitor. Nat Chem Biol 9:390-7 (2013) [PubMed]  Article 
Target
Name:
Isoform Bcl-X(L) of Bcl-2-like protein 1 (Bcl-xL)
Synonyms:
B-cell lymphoma-extra large protein (Bcl-xL) | B2CL1_HUMAN | BCL-xL | BCL2L | BCL2L1 | BCLX | Bcl-2-like protein 1 (Bcl-xL) | Isoform Bcl-X(L)
Type:
Homodimers/heterodimers with BAX, BAK and BCL2
Mol. Mass.:
26053.63
Organism:
Homo sapiens (Human)
Description:
gi_510901
Residue:
233
Sequence:
MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATAHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK
  
Inhibitor
Name:
BDBM109235
Synonyms:
(E)-2-(8-(2-(Benzo[d]thiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)-5-(4-phenylbutyl)thiazole-4-carboxylic acid (Compound 6)
Type:
Small organic molecule
Emp. Form.:
C31H28N4O2S2
Mol. Mass.:
552.71
SMILES:
OC(=O)c1nc(sc1CCCCc1ccccc1)-c1ccc2CCCC(=NNc3nc4ccccc4s3)c2c1 |w:26.28|
Structure:
Search PDB for entries with ligand similarity: